Advanced Medical EquipmentWAR:AME -0.92%14 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates WAR:AME with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Advanced Medical Equipment ranks worse than 122548.9% on this metric.
Advanced Medical Equipment (WAR:AME) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Advanced Medical Equipment EBITDA Margin % Related Terms
Advanced Medical Equipment EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:AME vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Advanced Medical Equipment's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Equipment EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Equipment's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Advanced Medical Equipment's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Equipment (WAR:AME) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Advanced Medical Equipment and its competitors. Over the past decade, Advanced Medical Equipment's EBITDA Margin % has ranged from 900.00 to 2,200.00. According to the industry distribution chart, Advanced Medical Equipment ranks #999999 out of 816 companies in the Medical Devices & Instruments industry.
Is Advanced Medical Equipment's EBITDA Margin % too high?
Advanced Medical Equipment's current EBITDA Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 900.00 to a high of 2,200.00. Based on the distribution chart, Advanced Medical Equipment ranks #999999 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Advanced Medical Equipment has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Equipment's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Equipment ranks #999999 out of 816 companies for EBITDA Margin %. This places Advanced Medical Equipment in the lower half of its industry. The industry median EBITDA Margin % is 7.48. Historically, Advanced Medical Equipment's own EBITDA Margin % has ranged from 900.00 to 2,200.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Advanced Medical Equipment and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Equipment's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Equipment stock overvalued right now?
Advanced Medical Equipment (WAR:AME) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Advanced Medical Equipment's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Advanced Medical Equipment (WAR:AME), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Advanced Medical Equipment SA operates in the vitro diagnostic medical device industry. It specializes in creating advanced diagnostic solutions that aim to improve the quality of life of patients around the world. It is a company that combines advanced engineering with medical science. The company develops technologies that transform traditional diagnostic methods into modern, precise tools.
14GF Score
Get the complete analysis for WAR:AME
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:AME has been successfully added to your 
